Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

zzlangerhans (99.67) Submitted: 5/22/2012 10:35:35 PM : Start Price: $0.44 CYCC Score: +15.12

I didn't close my last green thumb to run away from my painful 10000 share investment in Cyclacel, now more than 50% underwater. In CAPS, it pays to close green thumbs when they're down 50 points and take the accuracy hit. If you still believe your green thumb thesis, re-initiate the green thumb at a much lower start. If the stock actually doubles back to your original start price, you missed the chance to save your accuracy but you gained 100 pts instead of erasing a 50 pt deficit. And of course, you have a much greater opportunity to score 200, 300 or more given the lower start price.

CAPS finally decided not to screw me out of a 50 cent start price and gave me 44 cents instead. Bonus. If Cyclacel can actually stay afloat and generate some enthusiasm for sapacitabine from ongoing phase II trials ahead of SEAMLESS topline data, this could wind up being a two or three-bagger. However, I wouldn't bet on it. This boat has taken on some serious water and could well sink instead of sailing victoriously into port.

My mistakes on this investment were underestimating the duration of the SEAMLESS phase III trial, which has no projected date of complete enrollment let alone topline data, as well as a failure to understand the capital structure of Cyclacel which conceals a lot of shadow market cap in preferred stock. Live and learn.

pchop123 (71.80) Submitted: 5/16/2012 10:12:28 AM : Start Price: $0.44 CYCC Score: +15.12

I like the risk/reward equation at these prices right now

stainsolution (< 20) Submitted: 4/9/2012 9:52:19 AM : Start Price: $0.65 CYCC Score: -16.93

Small Cancer/Bio

RBuskey106 (< 20) Submitted: 3/21/2012 8:23:14 PM : Start Price: $0.63 CYCC Score: -12.37

Small cancer bio

nwarrior (< 20) Submitted: 7/27/2011 2:55:42 AM : Start Price: $1.18 CYCC Score: -56.21

This stock is poised to rise, already near it's 52 Week low. With a high insider net holding volume and low debt, this is an investment with great potential.

rwaddoups (< 20) Submitted: 1/3/2011 1:22:52 PM : Start Price: $1.50 CYCC Score: -69.55

yes

verbatum (< 20) Submitted: 10/5/2010 8:03:18 PM : Start Price: $1.62 CYCC Score: -82.23

Great Pipeline,Great PHASE II, Entering PHASE III, Shelf registered, Orphan Designation